Venture capital firm Index Ventures has launched new EUR150m life sciences fund which includes investments from GlaxoSmithKline and the venture capital affiliate of the Janssen pharmaceutical companies of Johnson & Johnson alongside Index's existing limited partners.
Index Ventures launches EUR150m life sciences fund